Frankfurt - Delayed Quote EUR

Apotea AB (publ) (V30.F)

8.90
0.00
(0.00%)
As of May 9 at 3:29:01 PM GMT+2. Market Open.

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
NameTitlePayExercisedYear Born
Mr. Par Svardson MD, CEO & Director 4.6M -- 1969
Mr. Johan Marild Chief Financial Officer -- -- 1982
Ms. Sarah Ahnstrom Deputy CEO & COO -- -- 1989
Mr. Stefan Eriksson HR Manager & Deputy CEO -- -- 1970

Apotea AB (publ)

Sveavägen 168
Stockholm, 113 46
Sweden
46 87 50 92 20 https://www.apotea.se
Sector: 
Healthcare
Full Time Employees: 
800

Description

Apotea AB (publ) operates an online pharmacy in Sweden. It offers products in the areas of allergy, face, child and parent, bite and sting, preparedness, animal, fever and aches, cold, home and household, aid, hair removal and shaving, hair care, hands and feet, intimate, dietary supplements, body care, stomach and intestine, food and beverage, mouth and teeth, toiletries, travel packaging and accessories, sex and lust, stop smoking, makeup, sun protection, wounds and injuries, sleep and sleep problems, training, weight control, vitamins and minerals, and eyes and ears. The company was founded in 2011 and is headquartered in Stockholm, Sweden.

Corporate Governance

Apotea AB (publ)’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 8, 2025 at 10:59 AM UTC

Apotea AB (publ) Earnings Date

Recent Events

Related Tickers